| Year |
Citation |
Score |
| 2023 |
Blanco-Carmona E, Narayanan A, Hernandez I, Nieto JC, Elosua-Bayes M, Sun X, Schmidt C, Pamir N, Özduman K, Herold-Mende C, Pagani F, Cominelli M, Taranda J, Wick W, von Deimling A, et al. Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas. Cell Reports. Medicine. 4: 101249. PMID 37883975 DOI: 10.1016/j.xcrm.2023.101249 |
0.699 |
|
| 2022 |
Demirdizen E, Al-Ali R, Narayanan A, Sun X, Varga JP, Steffl B, Brom M, Krunic D, Schmidt C, Schmidt G, Bestvater F, Taranda J, Turcan Ş. TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. Neuro-Oncology. PMID 36215168 DOI: 10.1093/neuonc/noac233 |
0.707 |
|
| 2022 |
Schönrock A, Heinzelmann E, Steffl B, Demirdizen E, Narayanan A, Krunic D, Bähr M, Park JW, Schmidt C, Özduman K, Pamir MN, Wick W, Bestvater F, Weichenhan D, Plass C, et al. MEOX2 homeobox gene promotes growth of malignant gliomas. Neuro-Oncology. PMID 35468210 DOI: 10.1093/neuonc/noac110 |
0.705 |
|
| 2021 |
Taranda J, Turcan S. 3D Whole-Brain Imaging Approaches to Study Brain Tumors. Cancers. 13. PMID 33920839 DOI: 10.3390/cancers13081897 |
0.691 |
|
| 2020 |
Narayanan A, Blanco-Carmona E, Demirdizen E, Sun X, Herold-Mende C, Schlesner M, Turcan S. Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq. Journal of Visualized Experiments : Jove. PMID 32925882 DOI: 10.3791/61542 |
0.338 |
|
| 2020 |
Wang Y, Wild AT, Turcan S, Wu WH, Sigel C, Klimstra DS, Ma X, Gong Y, Holland EC, Huse JT, Chan TA. Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas. Science Advances. 6: eaaz3221. PMID 32494639 DOI: 10.1126/Sciadv.Aaz3221 |
0.343 |
|
| 2018 |
Bunse L, Pusch S, Bunse T, Sahm F, Sanghvi K, Friedrich M, Alansary D, Sonner JK, Green E, Deumelandt K, Kilian M, Neftel C, Uhlig S, Kessler T, von Landenberg A, ... ... Turcan S, et al. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nature Medicine. PMID 29988124 DOI: 10.1038/S41591-018-0095-6 |
0.333 |
|
| 2018 |
Cahill D, Turcan S. Origin of Gliomas. Seminars in Neurology. 38: 5-10. PMID 29548046 DOI: 10.1055/S-0037-1620238 |
0.318 |
|
| 2017 |
Turcan S, Makarov V, Taranda J, Wang Y, Fabius AWM, Wu W, Zheng Y, El-Amine N, Haddock S, Nanjangud G, LeKaye HC, Brennan C, Cross J, Huse JT, Kelleher NL, et al. Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nature Genetics. PMID 29180699 DOI: 10.1038/S41588-017-0001-Z |
0.716 |
|
| 2015 |
Walsh LA, Roy DM, Reyngold M, Giri D, Snyder A, Turcan S, Badwe CR, Lyman J, Bromberg J, King TA, Chan TA. RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene. 34: 2189-203. PMID 24931164 DOI: 10.1038/Onc.2014.175 |
0.33 |
|
| 2015 |
Danussi C, Bose P, Parthasarathy P, Turcan S, Picketts D, Chan T, Huse J. Epig-06Atrx Deficiency Promotes Migratory Behavior In Glioma Cells Of Origin By Dysregulating Genome-Wide Chromatin Accessibility And Modulating Transcriptional Programs. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.06 |
0.382 |
|
| 2014 |
Gong Y, Zack TI, Morris LG, Lin K, Hukkelhoven E, Raheja R, Tan IL, Turcan S, Veeriah S, Meng S, Viale A, Schumacher SE, Palmedo P, Beroukhim R, Chan TA. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nature Genetics. 46: 588-94. PMID 24793136 DOI: 10.1038/Ng.2981 |
0.327 |
|
| 2013 |
Turcan S, Fabius AW, Borodovsky A, Pedraza A, Brennan C, Huse J, Viale A, Riggins GJ, Chan TA. Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. Oncotarget. 4: 1729-36. PMID 24077826 DOI: 10.18632/Oncotarget.1412 |
0.376 |
|
| 2013 |
Borodovsky A, Salmasi V, Turcan S, Fabius AW, Baia GS, Eberhart CG, Weingart JD, Gallia GL, Baylin SB, Chan TA, Riggins GJ. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget. 4: 1737-47. PMID 24077805 DOI: 10.18632/Oncotarget.1408 |
0.331 |
|
| 2013 |
Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AH, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, ... ... Turcan S, et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine. 19: 901-8. PMID 23793099 DOI: 10.1038/Nm.3217 |
0.336 |
|
| 2013 |
Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, ... ... Turcan S, et al. The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 45: 791-8. PMID 23685749 DOI: 10.1038/Ng.2643 |
0.315 |
|
| 2013 |
Rohle D, Popovici-Muller J, Palaskas N, Turcan S, Grommes C, Campos C, Tsoi J, Clark O, Oldrini B, Komisopoulou E, Kunii K, Pedraza A, Schalm S, Silverman L, Miller A, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science (New York, N.Y.). 340: 626-30. PMID 23558169 DOI: 10.1126/Science.1236062 |
0.335 |
|
| 2013 |
Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Turcan S, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/Neuonc/Not174 |
0.325 |
|
| 2012 |
Basappa J, Graham CE, Turcan S, Vetter DE. The cochlea as an independent neuroendocrine organ: expression and possible roles of a local hypothalamic-pituitary-adrenal axis-equivalent signaling system. Hearing Research. 288: 3-18. PMID 22484018 DOI: 10.1016/J.Heares.2012.03.007 |
0.718 |
|
| 2012 |
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, Wellen KE, O'Rourke DM, Berger SL, Chan TA, Levine RL, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature. 483: 474-8. PMID 22343901 DOI: 10.1038/Nature10860 |
0.305 |
|
| 2012 |
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R, Heguy A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 483: 479-83. PMID 22343889 DOI: 10.1038/Nature10866 |
0.306 |
|
| 2011 |
Graham CE, Basappa J, Turcan S, Vetter DE. The cochlear CRF signaling systems and their mechanisms of action in modulating cochlear sensitivity and protection against trauma. Molecular Neurobiology. 44: 383-406. PMID 21909974 DOI: 10.1007/S12035-011-8203-3 |
0.717 |
|
| 2011 |
Turcan S, Vetter DE, Maron JL, Wei X, Slonim DK. Mining functionally relevant gene sets for analyzing physiologically novel clinical expression data. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 50-61. PMID 21121032 |
0.59 |
|
| 2010 |
Basappa J, Turcan S, Vetter DE. Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear. Journal of Neuroscience Research. 88: 2976-90. PMID 20544827 DOI: 10.1002/Jnr.22449 |
0.725 |
|
| 2010 |
Turcan S, Slonim DK, Vetter DE. Lack of nAChR activity depresses cochlear maturation and up-regulates GABA system components: temporal profiling of gene expression in alpha9 null mice. Plos One. 5: e9058. PMID 20140217 DOI: 10.1371/Journal.Pone.0009058 |
0.656 |
|
| 2009 |
Vetter DE, Basappa J, Turcan S. Multiplexed isobaric tagging protocols for quantitative mass spectrometry approaches to auditory research. Methods in Molecular Biology (Clifton, N.J.). 493: 345-66. PMID 18839358 DOI: 10.1007/978-1-59745-523-7_21 |
0.69 |
|
| 2007 |
Vetter DE, Katz E, Maison SF, Taranda J, Turcan S, Ballestero J, Liberman MC, Elgoyhen AB, Boulter J. The alpha10 nicotinic acetylcholine receptor subunit is required for normal synaptic function and integrity of the olivocochlear system. Proceedings of the National Academy of Sciences of the United States of America. 104: 20594-9. PMID 18077337 DOI: 10.1073/Pnas.0708545105 |
0.708 |
|
| Show low-probability matches. |